(Q40461119)

20 September 2017

Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. (English)

1 reference

intrahepatic cholangiocarcinoma

20 September 2017

0 references

1 reference

1 reference

Yoh Zen

1

1 reference

20 September 2017

Kenichi Harada

2

1 reference

20 September 2017

Motoko Sasaki

3

1 reference

20 September 2017

Tse-Ching Chen

4

1 reference

20 September 2017

Miin-Fu Chen

5

1 reference

20 September 2017

Ta-Sen Yeh

6

1 reference

20 September 2017

Yi-Yin Jan

7

1 reference

20 September 2017

Shiu-Feng Huang

8

1 reference

20 September 2017

Yuji Nimura

9

1 reference

20 September 2017

Yasuni Nakanuma

10

1 reference

20 September 2017

1 April 2005

1 reference

20 September 2017

Laboratory Investigation

1 reference

20 September 2017

85

1 reference

20 September 2017

4

1 reference

20 September 2017

572-581

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700236

20 September 2017

0 references

cites work

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Transforming growth factor β and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Somatic alterations of the SMAD-2 gene in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Establishment and characterization of a cell line from a human cholangiocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Characterization of recombinant soluble human transforming growth factor-β receptor Type II (rhTGF-βsRII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Intraductal papillary neoplasia of the liver associated with hepatolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Isolation, culture and characterization of biliary epithelial cells from different anatomical levels of the intrahepatic and extrahepatic biliary tree from a mouse

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Microsatellite instability in intraductal papillary neoplasms of the biliary tract

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

Gene mutation of transforming growth factor beta1 type II receptor in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700236

7 January 2021

10.1038/LABINVEST.3700236

Identifiers

DOI

1 reference

20 September 2017

1 reference